Our Story
DeepCell was founded in 2015 with the simple idea that technology innovation was badly needed in the cannabinoid sciences.
The company set out to distinguish itself with a unique approach: heavy investments in research & development to illuminate discoveries for human wellness.
The company today owns two patents issued by the United States Patent Office (USPTO), owns trade secrets, trademarks, and developing technology in the digital space.
We set out to provide the industry with data, intelligence, and resources to push the frontier of cannabis science for human benefit.
Get in touch.
DeepCell licenses our core technology in regions across the United States and Canada. We actively seek new licensees across the world.
Data and quality science differentiate DeepCell from the competition.
We want to give our customers the edge in technology rooted in research, development, and best in class prototyping.